-
WGS Leiomyosarcoma subtypes
Study
EGAS00001005341
-
Mongolia Western HCC
Study
EGAS00001005364
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005368
-
Single cell copy number and chromatin accessibility in primary multiple myeloma cells
Study
EGAS00001005382
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Genomic characterization of co-existing biliary tract intraepithelial neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
Study
EGAS00001005402
-
Whole genome sequencing (bam files) of 5 samples of myxofibrosarcoma and 5 matched pairs
Study
EGAS00001005444
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.
Study
EGAS00001005437
-
Whole exome sequencing (bam files) of 55 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005442
-
Targeted-capture sequencing (bam files) of 81 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005443
-
TRACERx esophageal adenocarcinoma
Dac
EGAC00001000340
-
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
Study
EGAS00001005478
-
IMCISION DNAseq
Study
EGAS00001005466
-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Study
EGAS00001005501
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders
Study
EGAS00001005520
-
Genomic characterization of retinoblastoma (targeted sequencing)
Study
EGAS00001005550
-
Whole-transcriptome sequencing of hepatocellular carcinoma biopsies (TACE study)
Study
EGAS00001005558
-
The genomic landscape of early stage ovarian high grade serous carcinoma
Study
EGAS00001005567
-
Berlin Neuroblastoma Dataset Update 2021
Study
EGAS00001005604
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005581
-
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Study
EGAS00001005592
-
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Study
EGAS00001005617
-
PIK3CA mutation in a case of CTNNB1 mutant sinonasal glomangiopericytoma
Study
EGAS00001005653
-
Pre-neoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
Study
EGAS00001005656
-
MM samples for epigenomic translocation of H3K4me3 broad domains following super-enhancer hijacking
Study
EGAS00001005684
-
Targeted sequencing data and shallow whole genome sequencing data of Follicular lymphoma.
Study
EGAS00001005755
-
Clinical impact of immune checkpoint inhibitor (ICI) response, DNA damage repair (DDR) gene mutations and immune-cell infiltration in subtypes of metastatic melanoma
Study
EGAS00001005781
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001005784
-
Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
Study
EGAS00001005786
-
Study of pediatric hepatocellular carcinoma with BSEP deficiency
Dac
EGAC00001000191
-
Myeloma methylation
Study
EGAS00001005788
-
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Study
EGAS00001005791
-
RNA-seq data from 27 glioblastoma samples
Study
EGAS00001005807
-
Paired data of primary and relapse central nervous system lymphoma and testicular lymphoma
Study
EGAS00001005833
-
NLG-LBC-05 ctDNA
Study
EGAS00001005835
-
SPECTA RP-1759-AYA Sarcoma cohort
Study
EGAS00001005840
-
tFL with a PMBL GE signature
Study
EGAS00001005870
-
Patient-derived tumor organoids for personalized medicine in a rare case of hepatocellular carcinoma with neuroendocrine differentiation.
Study
EGAS00001005887
-
Origins and timing of emerging lesions in advanced renal cell carcinoma
Study
EGAS00001005897
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Genomic and transcriptome analysis for intrahepatic cholangiocarcinoma
Study
EGAS00001006007
-
Application of high-throughput, high-depth, targeted single-nucleus DNA sequencing in pancreatic cancer
Study
EGAS00001006024
-
Targeted analysis of cell-free circulating tumor DNA is suitable for early relapse and actionable target detection in patients with neuroblastoma
Study
EGAS00001006027
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
RP-1843 Arcagen - Gastrointestinal rare cancers (GI)
Study
EGAS00001006299
-
A multi-center genome-wide association study for nasopharyngeal carcinoma
Study
EGAS00001006062
-
Genomic and transcriptomic analysis of baseline PDAC patients' tumors from the OXIRI phase 1b clinical trial
Study
EGAS00001006073
-
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Study
EGAS00001006118
-
USARC 10X Genomics Single Cell DNA Sequencing Data
Study
EGAS00001006144
-
Whole exome sequencing study of cholesteatoma patients from affected families
Study
EGAS00001006147
-
Genomic profiling of metastatic basal cell carcinoma reveals candidate drivers of disease and therapeutic targets
Study
EGAS00001006148
-
Molecular and clinical diversity in primary central nervous system lymphoma: a LOC Network study
Study
EGAS00001006191
-
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Study
EGAS00001006196
-
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Study
EGAS00001006200
-
MGP Panel: a comprehensive targeted genomics panel for molecular profiling of multiple myeloma patients
Study
EGAS00001006222
-
Salivary Gland Cancer TSO500 dataset
Study
EGAS00001006232
-
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
Study
EGAS00001006293
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001006306
-
Long-read sequencing for cell-free DNA analysis (human)
Study
EGAS00001006328
-
Intratumoural heterogeneity and immune modulation in lung adenocarcinoma of female smokers and never smokers
Study
EGAS00001006331
-
Molecular determinants of outcomes in relapsed mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Study
EGAS00001006342
-
Placebo-only arm transcriptomic analysis of the phase 3 PROTECT clinical trial
Study
EGAS00001006344
-
Clonal dominance defines metastatic dissemination in pancreatic cancer
Study
EGAS00001006358
-
Whole exome-sequencing of pediatric and adult H3-K27M diffuse midline glioma
Study
EGAS00001006431
-
Glioma exome array DAC
Dac
EGAC00001000345
-
Whole genome landscape of 25 metastatic cutaneous squamous cell carcinoma cSCC patients
Study
EGAS00001006378
-
Molecular profiling of EBV associated diffuse large B-cell lymphoma
Study
EGAS00001006400
-
DNA methylation-based prognostic subtypes of chordoma tumors in tissue
Study
EGAS00001006406
-
T cell reactivity of MHC epitopes
Study
EGAS00001006445
-
Colorectal cancer study
Study
EGAS00001006489
-
Immune microenvironment and lineage tracing help deciphering Rosette-forming GlioNeuronal Tumors: a multi-omic analysis of 9 cases
Study
EGAS00001006502
-
Reliable assessment of telomere maintenance mechanisms in neuroblastoma
Study
EGAS00001006510
-
Renal Cell Carcinoma Tumors From S-TRAC trial (NCT00375674) Whole Transcriptome Sequencing
Study
EGAS00001006528
-
Renal Cell Carcinoma Tumors From S-TRAC trial (NCT00375674) Exome Sequencing
Study
EGAS00001006529
-
Significant and pervasive effects of RNA degradation on Nanopore direct RNA sequencing
Study
EGAS00001006542
-
A living biobank of patient-derived ductal carcinoma in situ Mouse-INtraDuctal xenografts identifies factors associated with risk of invasive progression
Study
EGAS00001006554
-
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures
Study
EGAS00001006576
-
Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models: validation cohort
Study
EGAS00001006582
-
Somatic mutations predict an aggressive phenotype in meningioma but do not drive grade progression
Study
EGAS00001006585
-
Defective homologous recombination in HCC
Study
EGAS00001006599
-
microRNA and isomiR profiling of Stage 1 epithelial ovarian carcinoma
Study
EGAS00001006617
-
scRNA-seq of patient-derived PDAC organoids and matched CAFs
Study
EGAS00001006661
-
Follicular lymphoma at diagnosis, treated in first line with immunochemotherapy
Study
EGAS00001006674
-
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
Study
EGAS00001006678
-
Neoadjuvant Chemo or Combined Chemo-Radiation Therapy of Pancreatic Ductal Adenocarcinoma Yields Fundamentally Different Proteome Biology of the Residual Tumor Mass
Study
EGAS00001006739
-
The Iberian Roma genetic variant server
Study
EGAS00001006758
-
Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
Study
EGAS00001006793
-
Exome sequencing of HCV+ lymphoma
Study
EGAS00001006860
-
TK-EPN862 - Patient-dervied xenograft model of Posterior Fossa A Ependymoma - WGS
Study
EGAS00001006843
-
TK-EPN862 - Patient-dervied xenograft model of Posterior Fossa A Ependymoma - RNAseq
Study
EGAS00001006844
-
Clonal dynamics of normal hepatocyte expansions in homeostatic human livers and their association with the biliary epithelium
Study
EGAS00001006962
-
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild type primary glioblastoma
Study
EGAS00001006989
-
Single cell epigenomic study of H3-K27M mutant diffuse midline glioma across age and location
Study
EGAS00001007035
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077
-
RNA sequencing of a glioblastoma PDX cohort
Study
EGAS00001007119
-
AMC Neuroblastoma Study
Dac
EGAC00001000047
-
Neuroblastoma Data Access Committee
Dac
EGAC00001000085
-
Barts Cancer Institute - Follicular Lymphoma Whole Genome Sequencing Project Data Access Committee
Dac
EGAC00001000086